News & Blog

News & Blog

News | Nov 11 2026

November 2026 – Advocacy Newsletter

Advocacy
News | Nov 10 2026

Press Release: Global Ataxia Advocacy Organizations Unite to Host Largest International Congress for Ataxia Research in Atlanta

Research
News | Nov 9 2026

Press Release: Larimar Therapeutics Completes Rolling BLA Submission Seeking Accelerated Approval of Nomlabofusp for Friedreich’s Ataxia

Industry News
News | Nov 4 2026

Community Statement: Solid Biosciences

Industry News
News | Oct 26 2026

Press Release: Solid Biosciences Announces European Commission Orphan Designation for SGT-212 and Continued Progress in the FALCON Trial in Friedreich’s Ataxia

Industry News
News | Oct 13 2026

Webinar Recording: Lexeo Therapeutics September 2026

FARA News | Industry News
News | Oct 7 2026

October 2026 – Advocacy Newsletter

Advocacy
News | Oct 7 2026

Community Statement: Neurocrine Biosciences announces the first clinical study of NBIB-223 (the FACET™ study), An investigational gene therapy for FA

Industry News
News | Sep 24 2026

Press Release & Community Statement: Lexeo Therapeutics Enters Into Agreement to Acquire Mantle Therapeutics and Announces Multiple New Strategic Collaborations

Industry News
News | Sep 17 2026

FARA Marks 18 Years of Empowering Athletes Through the Ataxian Athlete Initiative (AAI)

rideATAXIA
News | Sep 12 2026

September 2026 – Advocacy Newsletter

Advocacy
News | Aug 25 2026

FA Community Conversations – FDA’s Accelerated Approval Pathway: Recording Available on YouTube

Education